EU indices still up | TA focus on CRH Plc


European stocks report | Compass Group | Deutsche Boerse | Enel | Novartis...

Stocks (1)

Yesterday, European stocks lacked momentum. The Stoxx Europe 600 eased 0.20%, Germany's DAX edged down 0.08%, France's CAC 40 dipped 0.07%, and the U.K.'s FTSE 100 was down 0.28%.

56% of STOXX 600 constituents traded lower or unchanged yesterday.
79% of the shares trade above their 20D MA vs 84% Friday (above the 20D moving average).
84% of the shares trade above their 200D MA vs 84% Friday (above the 20D moving average).

The Euro Stoxx 50 Volatility index added 1.05pt to 22.49, a new 52w high.

3mths relative high: Banks, Energy
3mths relative low: Chemicals, Food & Beverage, Healthcare

Europe Best 3 sectors
energy, basic resources, banks

Europe worst 3 sectors
health care, telecommunications, food & beverage

The 10yr Bund yield fell 1bp to -0.58% (below its 20D MA). The 2yr-10yr yield spread fell 0bp to -17bps (above its 20D MA).

GE 08:00: Q3 GDP Growth Rate QoQ final, exp.: -9.8%
GE 08:00: Q3 GDP Growth Rate YoY final, exp.: -11.3%
FR 08:45: Nov Business Confidence, exp.: 93
FR 08:45: Nov Business Climate Indicator, exp.: 90
GE 10:00: Nov Ifo Current Conditions, exp.: 90.3
GE 10:00: Nov Ifo expectations, exp.: 95
GE 10:00: Nov Ifo Business Climate, exp.: 92.7
UK 11:00: BoE Haskel speech
GE 11:40: 2-Year Schatz auction, exp.: -0.8%
UK 12:00: Nov CBI Distributive Trades, exp.: -23
GE 14:00: Bundesbank Mauderer speech
EC 14:15: ECB Schnabel speech
GE 17:00: Bundesbank Beermann speech

In Asian trading hours, EUR/USD edged up to 1.1845 and GBP/USD advanced to 1.3330. USD/JPY held gains at 104.55.

Spot gold extended its decline to $1,825 an ounce.

Compass Group, a food service company, posted full-year underlying EPS declined 77.8% on year to 18.6p and underlying operating profit slid 69.7% to 561 million pounds on revenue of 20.2 billion pounds, down 18.8%. 

CRH Plc, a building materials firm, issued a trading update: "Cumulative nine-month sales to the end of September amounted to 20.6 billion dollars, a decrease of 3% compared with the corresponding period in 2019, (...) EBITDA for the period was 3.4 billion dollars, up 1% on prior year and up 2% on a like-for-like basis (...) we expect full-year EBITDA to be in excess of 4.4 billion dollars for 2020."   
From a technical point of view, the stock is facing the key horizontal resistance around 3117p. A break above this level, would trigger the end of the trading range in place since June 2020 and would set targets towards the previous all-time high at 3430p and 3600p in extension.

Source: TradingView, GAIN Capital

Lloyds Banking Group and NatWest, the two British banks, were downgraded to "hold" from "buy" at HSBC.

Deutsche Boerse, a stock market operator, said from September 2021, the benchmark index DAX will be expanded by ten members, to a total of 40 constituents.

Natixis, an investment bank, was downgraded to "underweight" from "equalweight" at Morgan Stanley.

Novartis, a pharmaceutical giant, announced a 2.5 billion dollars share buyback plan, starting immediately and will last into the first half of 2021.

Roche, a giant drugmaker, reported that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application for its Xofluza as a treatment to prevent influenza.

Credit Suisse, a banking group, said it expects to book a 450 million dollars impairment charge on York Capital Management in 4Q results. The bank added: "The capital impact of this impairment is currently estimated to reduce our 4Q20 CET1 ratio by approximately 7 basis points. This impairment does not change our existing guidance for dividends and capital distributions in 2020 and 2021."

Danske Bank, a Danish bank, was downgraded to "underweight" from "equalweight" at Morgan Stanley.

Swedbank, a Nordic-Baltic banking group, was downgraded to "sell" from "neutral" at Goldman Sachs.

Hennes & Mauritz, a Swedish clothing-retail company, was upgraded to "buy" from "sell" at Goldman Sachs.

UBS Group (UBSG): $0.1825

More from Equities

Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.

Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.

Open an Account